RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum
RxSight, Inc. (NASDAQ: RXST), a company specializing in ophthalmic medical devices for post-cataract surgery vision customization, has announced its participation in the upcoming Stifel Virtual Ophthalmology Forum. The company's management team will engage in a fireside chat on Tuesday, May 27, 2025, at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. Interested parties can access both the live and archived versions of the presentation through RxSight's investor relations website at investors.rxsight.com.
RxSight, Inc. (NASDAQ: RXST), un'azienda specializzata in dispositivi medici oftalmici per la personalizzazione della visione dopo la chirurgia della cataratta, ha annunciato la sua partecipazione al prossimo Stifel Virtual Ophthalmology Forum. Il team di gestione dell'azienda parteciperà a una conversazione informale il martedì 27 maggio 2025, alle 10:30 ora del Pacifico / 13:30 ora della costa Est. Gli interessati potranno accedere sia alla versione in diretta che a quella registrata della presentazione tramite il sito web delle relazioni con gli investitori di RxSight all'indirizzo investors.rxsight.com.
RxSight, Inc. (NASDAQ: RXST), una empresa especializada en dispositivos médicos oftálmicos para la personalización de la visión después de la cirugía de cataratas, ha anunciado su participación en el próximo Stifel Virtual Ophthalmology Forum. El equipo directivo de la empresa participará en una charla informal el martes 27 de mayo de 2025, a las 10:30 a. m. hora del Pacífico / 1:30 p. m. hora del Este. Las personas interesadas podrán acceder tanto a la versión en vivo como a la archivada de la presentación a través del sitio web de relaciones con inversores de RxSight en investors.rxsight.com.
RxSight, Inc. (NASDAQ: RXST)는 백내장 수술 후 시력 맞춤화용 안과 의료기기 전문 회사로, 다가오는 Stifel Virtual Ophthalmology Forum에 참여한다고 발표했습니다. 회사 경영진은 2025년 5월 27일 화요일, 태평양 시간 오전 10:30 / 동부 시간 오후 1:30에 진행되는 비공식 대화에 참여할 예정입니다. 관심 있는 분들은 RxSight 투자자 관계 웹사이트인 investors.rxsight.com을 통해 생중계 및 녹화된 프레젠테이션 모두를 시청하실 수 있습니다.
RxSight, Inc. (NASDAQ : RXST), une entreprise spécialisée dans les dispositifs médicaux ophtalmiques pour la personnalisation de la vision après une chirurgie de la cataracte, a annoncé sa participation au prochain Stifel Virtual Ophthalmology Forum. L'équipe de direction de la société participera à une discussion informelle le mardi 27 mai 2025 à 10h30, heure du Pacifique / 13h30, heure de l'Est. Les personnes intéressées pourront accéder aux versions en direct et archivées de la présentation via le site web des relations investisseurs de RxSight à l'adresse investors.rxsight.com.
RxSight, Inc. (NASDAQ: RXST), ein Unternehmen, das sich auf ophthalmologische Medizinprodukte zur individuellen Anpassung der Sehkraft nach Kataraktoperationen spezialisiert hat, hat seine Teilnahme am kommenden Stifel Virtual Ophthalmology Forum angekündigt. Das Management-Team des Unternehmens wird am Dienstag, den 27. Mai 2025, um 10:30 Uhr Pacific Time / 13:30 Uhr Eastern Time an einem informellen Gespräch teilnehmen. Interessierte können sowohl die Live- als auch die aufgezeichnete Version der Präsentation über die Investor-Relations-Website von RxSight unter investors.rxsight.com abrufen.
- None.
- None.
ALISO VIEJO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Stifel Virtual Ophthalmology Forum.
RxSight’s management is scheduled to participate in a fireside chat on Tuesday, May 27, 2025, at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. A live and archived webcast of the presentation will be available on the Company’s investor relations website at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When is RxSight (RXST) presenting at the Stifel Virtual Ophthalmology Forum 2025?
Where can I watch RxSight's (RXST) presentation at the Stifel Ophthalmology Forum?
What does RxSight (RXST) specialize in?
What type of event is RxSight (RXST) participating in for May 2025?
